(Q45362932)

English

Will the increased prevalence of nonalcoholic steatohepatitis (NASH) in the age of better hepatitis C virus therapy make NASH the deadlier disease?

scientific article published in October 2011

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

13 December 2017

0 references

Will the increased prevalence of nonalcoholic steatohepatitis (NASH) in the age of better hepatitis C virus therapy make NASH the deadlier disease? (English)

1 reference

Europe PubMed Central

13 December 2017

steatohepatitis

0 references

Hepatitis C virus

1 reference

based on heuristic

inferred from title

author name string

Mary E Rinella

1

1 reference

Europe PubMed Central

13 December 2017

language of work or name

0 references

publication date

1 October 2011

1 reference

Europe PubMed Central

13 December 2017

1 reference

Europe PubMed Central

13 December 2017

54

1 reference

Europe PubMed Central

13 December 2017

4

1 reference

Europe PubMed Central

13 December 2017

1118-1120

1 reference

Europe PubMed Central

13 December 2017

The prevalence of hepatitis C virus infection in the United States, 1999 through 2002

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24634

21 January 2018

The natural history of nonalcoholic fatty liver disease with advanced fibrosis or cirrhosis: an international collaborative study.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24634

21 January 2018

Prevalence, metabolic features, and prognosis of metabolically healthy obese Italian individuals: the Cremona Study

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24634

21 January 2018

Long-term outcomes of cirrhosis in nonalcoholic steatohepatitis compared with hepatitis C.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24634

21 January 2018

Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy: a prospective study.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24634

21 January 2018

Influence of ethnicity on histological differences in non-alcoholic fatty liver disease

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24634

21 January 2018

Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24634

21 January 2018

Meta-analysis of the influence of I148M variant of patatin-like phospholipase domain containing 3 gene (PNPLA3) on the susceptibility and histological severity of nonalcoholic fatty liver disease

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24634

21 January 2018

Reinitiation involving upstream ORFs regulates ATF4 mRNA translation in mammalian cells

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24634

21 January 2018

Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24634

21 January 2018

A placebo-controlled trial of pioglitazone in subjects with nonalcoholic steatohepatitis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24634

21 January 2018

The role of diabetes in hepatocellular carcinoma: a case-control study among United States Veterans

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24634

21 January 2018

Risk factors for hepatocellular carcinoma: synergism of alcohol with viral hepatitis and diabetes mellitus

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24634

21 January 2018

A prospective study of the rate of progression in compensated, histologically advanced chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24634

21 January 2018

The incidence and risk factors of hepatocellular carcinoma in patients with nonalcoholic steatohepatitis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24634

21 January 2018

Risk of cardiovascular disease in patients with nonalcoholic fatty liver disease

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24634

21 January 2018

Identifiers

10.1002/HEP.24634

1 reference

Europe PubMed Central

13 December 2017

release_65wbnsbd2jfohjmmwsrvb74g74

1 reference

https://api.fatcat.wiki/v0/release/65wbnsbd2jfohjmmwsrvb74g74

24 November 2022

based on heuristic

mapped directly with Wikidata item

1 reference

Europe PubMed Central

13 December 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45362932&oldid=1840478211"